Breast cancer stem cells: something out of notching?

Hannah Harrison, Gillian Farnie, Keith R Brennan, Robert B Clarke

Journal: Cancer research 2011;70(22):8973-6

PMID: 21045140

Full Text on Silverchair Information Systems View on PubMed

Abstract

We and others have established that the developmental Notch receptor signaling pathway is active in breast cancer cell lines, as well as in preinvasive and invasive primary samples. Recently, a role for Notch in regulating the hierarchy of stem and progenitor cells in both normal and cancer epithelium has been elucidated. Because inhibiting the Notch receptor signaling pathway is a possible future breast cancer therapy, here, we review the expression and activity of the different ligands and receptors and summarize the various ways in which the pathway's activity can be inhibited, and the likely effects of inhibition on different tumor cell subpopulations.

Address: Breast Biology Group, School of Cancer and Enabling Sciences, Paterson Institute for Cancer Research, University of Manchester;, Manchester, United Kingdom.

DOI: 10.1158/0008-5472.CAN-10-1559

Link outs

Free resources

Medical:

https://medlineplus.gov/breastcancer.html

Subscription / membership required

Full Text Sources:

https://aacrjournals.org/cancerres/article-lookup/...

MeSH Terms: Adaptor Proteins, Signal Transducing, Antineoplastic Agents, Breast Neoplasms, Calcium-Binding Proteins, Female, Humans, Intercellular Signaling Peptides and Proteins, Neoplastic Stem Cells, Proto-Oncogene Proteins, Receptor, Notch4, Receptors, Notch, Signal Transduction